About Evolving Past...
Evolving Past Alzheimer’s
Dr Nate Bergman is absolutely convinced that Alzheimer’s and other brain diseases are generally treatable and reversible. Early translational evidence is supports this belief. The Evolving Past Alzheimer’s podcast is committed to bring you the highest caliber information about what you can do to identify, prevent, and treat Alzheimer’s disease.The show’s secondary goal is to use Alzheimer’s and cognition as a platform to explore consciousness and the human experience in it’s “second half of life.” Topics include emerging technologies, transhumanism, traditional medicinal approaches, spiritual conversations, and stories of people living with – and through – Alzheimer’s. This show brings you conversations with experts around the world that are leading the charge in treatment and prevention of Alzheimer’s and other brain disease.
Why “Evolving Past”? Part of the show’s content attempts to reconcile the challenges of living in the “second half” of your life in an increasingly digital/synthetic culture that appears to be evolving into something more.
The Website and Company
Evolving Past Alzheimer’s is the culmination of years of study and experimental work and will bring you evidence informed information that you can apply practically to your day-to-day quest for better living. We encourage you to explore the resources and interact with us on this website or on Facebook.
Why are we selling stuff?
You can’t have a mission if you don’t have a margin. Though we are very passionate about our work the amount of time and expense it takes to bring you this information is considerable. Thus, we have opted to add value to our listeners and supporters by bringing them information and products that will impact their lives in the most profound ways.
Have a Question for the Podcast? Have a Comment?
Or just want to stay abreast of the latest and greatest Alzheimer’s and “mind altering” news by joining our mailing list?
Connect with us here.
Dr. Nate Bergman
Dr Nate Bergman’s journey to starting the Evolving Past Alzheimer’s show was born out of both personal experience and frustration with the current state of affairs in medicine. After a short stint in performance art, several years in spiritual retreat and study he embarked on a career in medicine. Nate opted to become a doctor of osteopathic medicine because of the profession’s acknowledgment of the multidimensional nature of humankind, i.e., physical and spiritual beings.
Personal Health Struggles
Nate’s interest in brain health, prevention, and disease treatments was spawned in part by his own illness. Over the course of his second and third years of medical training he suffered severe memory loss. This left him shaken and with very few people to confide in…and he learned first hand what it feels like to “lose your mind.” Applying the core principles of Functional Medicine — ascertaining the root drivers of his illness — and with support of his family, Nate’s memory and brain function improved to the best shape of his adult life. These experiences and his curiosity for “doing things a better way” have led him to share these ideas and more on the Evolving Past Alzheimer’s platform.
While on this journey Nate has been afforded extraordinary opportunities including an Intramural Research Training Award at the National Institutes of Health (medicinal chemistry and drug design), a term with health information technology giant Cerner Corporation, and fellowship training in Geriatric Medicine at the Cleveland Clinic.
Over the past 10 years, Nate has benefited from mentorship relationships with Drs Mark Hyman, Dale Bredesen, James O’keefe, Patrick Hanaway, Dan Kalish, Robert Hedaya and many others.
Currently, Nate is a board certified physician and Clinical Assistant Professor of Medicine working in a large tertiary care hospital in Cleveland. During the day he works as a Functional Medicine physician with a focus on brain health and the prevention and treatment of early Alzheimer’s disease. His current research is focused on an intervention for individuals suffering from Mild Cognitive Impairment and early stages of Alzheimer’s and other neurodegenerative conditions.